Characteristic or Investigation | Total (n= 6658) | Mild Stroke (n= 4114, 62.7 %) | Moderate to Severe Stroke (n= 2444, 37.3%) | P-Value |
---|---|---|---|---|
Age, Mean, years | 54.4 ±12.8 | 54.4 ±12.3 | 54.9 ±13.7 | <0.001 |
Male Sex | 5385 (82.1) | 3401 (82.7) | 1984 (81.2) | 0.13 |
Diabetes | 3688 (56.2) | 2306 (56.1) | 1382 (56.5) | 0.69 |
Hypertension | 4834 (73.7) | 3102 (75.4) | 1732 (70.9) | <0.001 |
Dyslipidemia | 3306 (50.4) | 2150 (52.3) | 1156 (47.3) | <0.001 |
Prior Stroke | 754 (11.5) | 461 (11.2) | 293 (12.0) | 0.34 |
Coronary Artery Disease | 765 (11.7) | 454 (11.0) | 311 (12.7) | 0.04 |
Atrial Fibrillation | 482 (7.3) | 225 (5.5) | 257 (10.5) | <0.001 |
Active Smoking | 1959 (29.9) | 1225 (29.8) | 734 (30.0) | 0.83 |
Obesity (BMI ≥ 30 kg/m2) | 1661 (25.3) | 1063 (25.8) | 598 (24.5) | 0.22 |
Hypertriglyceridemia | ||||
Low Normal (≤ 1.1mmol/L) | 2019 (30.8) | 1184 (28.8) | 835 (34.2) | <0.001 |
High Normal (1.2 – 1.7 mmol/L) | 2142 (32.7) | 1334 (32.4) | 808 (33.1) | |
Borderline High (1.8 – 2.2 mmol/L) | 1072 (16.3) | 699 (17.0) | 373 (15.3) | |
High (≥ 2.3 mmol/L) | 1325 (20.2) | 897 (21.8) | 428 (17.5) | |
IV Thrombolysis given | 779 (11.9) | 123 (3.0) | 656 (26.8) | <0.001 |
Complications during admission | 422 (6.4) | 97 (2.4) | 325 (13.3) | <0.001 |
Prognosis 90-Days (n= 5021) | ||||
Good (mRS 0-2) | 3543 (70.6) | 2692 (84.1) | 851 (46.7) | <0.001 |
Poor (mRS 3-6) | 1478 (29.4) | 508 (15.9) | 970 (53.3) | |
Mortality at 90-Days | 179 (3.6) | 41 (1.3) | 138 (7.6) | <0.001 |
One Year Outcome | ||||
Recurrent Stroke (Ischemic or Hemorrhagic) | 122 (2.4) | 84 (2.6) | 38 (2.1) | 0.28 |
Myocardial Infarction (fatal or non-fatal) | 39 (0.8) | 27 (0.8) | 12 (0.7) | 0.51 |
All-Cause Mortality | 228 (4.5) | 61 (1.9) | 167 (9.1) | <0.001 |
Cardiac Arrest | 55 (1.1) | 17 (0.5) | 38 (2.1) | <0.001 |
Cardiac Revascularization (CABG or PCI) | 39 (0.8) | 26 (0.8) | 13 (0.7) | 0.76 |
Total MACE at one year | 401 (6.1) | 180 (4.4) | 221 (9.0) | <0.001 |